FindTrial
Sign In

Development of Biomarkers for Early Detection of Gastric Cancer Using Metabolomics

Development of Metabolomics-Based Biomarkers for Early Detection of Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005597
Enrollment
40
Registered
2020-11-13
Start date
2019-11-04
Completion date
Unknown
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 20 to 80 who were diagnosed with gastric cancer by gastroscopy

Exclusion criteria

Exclusion criteria: ? Patients who have difficulty stopping gastritis drugs ? Patients who took antibiotics within 4 weeks ? Patients who received treatment for Helicobacter bacteria ? Failure to obtain informed consent from the patient or guardian ? In case the patient is a vulnerable target who cannot make a decision

Design outcomes

Primary

MeasureTime frame
Differences in metabolites obtained in tissue—

Secondary

MeasureTime frame
Pathway analysis using metabolites—

Countries

Korea, Republic of

Contacts

Public ContactSeong Ji Choi

Korea University Anam Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026